Revenue: The sum of all revenue fields included for a company's operating activities.
Kiniksa Pharmaceuticals International, plc (KNSA) had Revenue of $156.80M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$156.80M |
$17.83M |
|
$18.60M |
|
$138.19M |
|
$136.64M |
|
$20.16M |
|
$2.72M |
|
$22.88M |
|
$22.88M |
|
$17.83M |
|
$17.83M |
|
$17.83M |
|
$17.83M |
|
$20.16M |
|
$20.52M |
|
73.44M |
|
77.94M |
|
$0.24 |
|
$0.23 |
|
| Balance Sheet Financials | |
$420.31M |
|
$1.08M |
|
$240.84M |
|
$661.15M |
|
$117.83M |
|
-- |
|
$48.32M |
|
$166.14M |
|
$495.01M |
|
$479.26M |
|
$495.01M |
|
74.03M |
|
| Cash Flow Statement Financials | |
$50.41M |
|
$-55.42M |
|
$13.47M |
|
$183.58M |
|
$192.04M |
|
$8.46M |
|
$16.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.57 |
|
-- |
|
-- |
|
-- |
|
-- |
|
88.14% |
|
12.86% |
|
12.86% |
|
-- |
|
14.59% |
|
11.37% |
|
$50.15M |
|
-- |
|
-- |
|
-- |
|
0.24 |
|
0.39 |
|
4.91 |
|
18.32 |
|
3.60% |
|
3.72% |
|
2.70% |
|
3.60% |
|
$6.69 |
|
$0.64 |
|
$0.65 |
|